1995
DOI: 10.1182/blood.v86.7.2789.2789
|View full text |Cite
|
Sign up to set email alerts
|

Epstein-Barr virus modulates de novo protein synthesis in human neutrophils

Abstract: Neutrophils and macrophages represent the first line of defense against microbial invaders. However, the role of phagocytes in host response to viral infection is poorly understood. We have previously shown that Epstein-Barr virus (EBV) interacts with human monocytes and modulates cytokine production in this cell type, but its effects on neutrophils are still unknown. In the present study, we investigated the presence of EBV receptor (CR2 or CD21) on neutrophils by cytofluorometry using five different anti-CD2… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
5
0

Year Published

2000
2000
2019
2019

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 16 publications
(6 citation statements)
references
References 34 publications
1
5
0
Order By: Relevance
“…Cells infected with purified virus were cultured in MEM supplemented with 5% heat-inactivated FBS until 90% of mortality was observed. Supernatant was then filtered on 0.45 µm pore filter and viral particles were concentrated by ultracentrifugation [37] . Uninfected-BHK-21 cells supernatant was treated as above to produce mock control.…”
Section: Methodsmentioning
confidence: 99%
“…Cells infected with purified virus were cultured in MEM supplemented with 5% heat-inactivated FBS until 90% of mortality was observed. Supernatant was then filtered on 0.45 µm pore filter and viral particles were concentrated by ultracentrifugation [37] . Uninfected-BHK-21 cells supernatant was treated as above to produce mock control.…”
Section: Methodsmentioning
confidence: 99%
“…Various investigations have focused on a correlation between Epstein-Barr virus infection and cytokine expression. Although Epstein-Barr virus preferentially infects B cells, it is well known that the virus is capable of replicating in epithelial cells of the oro- Total A1 A2 A3 B1 B2 B3 C1 C2 C3 Controls 6 11 3 2 0 22 Not applicable HIV/no oral lesions 1 8 17 12 1 39 3 8 1 0 4 11 0 0 12 HIV/candidiasis 0 1 4 3 0 8 0 0 0 0 2 1 0 1 4 HIV/oral hairy leukoplakia 1 0 0 4 0 5 2 1 0 0 0 0 0 0 2 Total 8 20 24 21 1 5 9 1 0 6 12 0 1 18 pharynx, as well as binding monocytes and neutrophils (5,18,19). Thus, it is of no surprise that Epstein-Barr virus has been shown to support the expression of IL-1 and IL-1 receptor antagonist (2,41), IL-4 (38), IL-10 (6, 52), IL-8, tumor necrosis factor (TNF)-a and TNF-b (28).…”
mentioning
confidence: 99%
“…The cellular receptor involved in the interaction of the glycoprotein gp350 with the PMN surface has yet to be characterized. Previous data from our laboratory suggested that this receptor is distinct from the well-defined CD21 (CR2) antigen used by EBV for entry into B cells; indeed, the CD21 antigen is not expressed at the surface of PMN [9] and moreover anti-CD21 antibodies did not interfere with the attachment of EBV to PMN and monocytes [8,9]. At the present time, it is unknown if EBV uses the same alternative receptor on PMN and monocytes.…”
Section: Discussionmentioning
confidence: 84%
“…Increased LTB 4 biosynthesis could be a way for the virus to attract more PMN (and other leucocytes responsive to the chemotactic effect of LTB 4 ) at the site of infection. Previous results from our laboratory have shown that EBV induces expression of various chemokines and immunoregulatory molecules in monocytes and PMN [8,9,11,13] and it was suggested that up-regulation of MIP-1a , which is chemotactic for B cells, may enhance recruitment of B cells to the site of infection [13]. Thus, modulation of cytokines and leukotrienes in monocytes and PMN might be part of an important immune process which dictates the outcome of EBV infections.…”
Section: Discussionmentioning
confidence: 95%